Automated Detection and Segmentation of Multiple Sclerosis Lesions Using Ultra-High-Field MP2RAGE.
Journal
Investigative radiology
ISSN: 1536-0210
Titre abrégé: Invest Radiol
Pays: United States
ID NLM: 0045377
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
pubmed:
5
3
2019
medline:
7
1
2020
entrez:
5
3
2019
Statut:
ppublish
Résumé
The aim of this study was to develop a new automated segmentation method of white matter (WM) and cortical multiple sclerosis (MS) lesions visible on magnetization-prepared 2 inversion-contrast rapid gradient echo (MP2RAGE) images acquired at 7 T MRI. The proposed prototype (MSLAST [Multiple Sclerosis Lesion Analysis at Seven Tesla]) takes as input a single image contrast derived from the 7T MP2RAGE prototype sequence and is based on partial volume estimation and topological constraints. First, MSLAST performs a skull-strip of MP2RAGE images and computes tissue concentration maps for WM, gray matter (GM), and cerebrospinal fluid (CSF) using a partial volume model of tissues within each voxel. Second, MSLAST performs (1) connected-component analysis to GM and CSF concentration maps to classify small isolated components as MS lesions; (2) hole-filling in the WM concentration map to classify areas with low WM concentration surrounded by WM (ie, MS lesions); and (3) outlier rejection to the WM mask to improve the classification of small WM lesions. Third, MSLAST unifies the 3 maps obtained from 1, 2, and 3 processing steps to generate a global lesion mask. Quantitative and qualitative assessments were performed using MSLAST in 25 MS patients from 2 research centers. Overall, MSLAST detected a median of 71% of MS lesions, specifically 74% of WM and 58% of cortical lesions, when a minimum lesion size of 6 μL was considered. The median false-positive rate was 40%. When a 15 μL minimal lesions size was applied, which is the approximation of the minimal size recommended for 1.5/3 T images, the median detection rate was 80% for WM and 63% for cortical lesions, respectively, and the median false-positive rate was 33%. We observed high correlation between MSLAST and manual segmentations (Spearman rank correlation coefficient, ρ = 0.91), although MSLAST underestimated the total lesion volume (average difference of 1.1 mL), especially in patients with high lesion loads. MSLAST also showed good scan-rescan repeatability within the same session with an average absolute volume difference and F1 score of 0.38 ± 0.32 mL and 84%, respectively. We propose a new methodology to facilitate the segmentation of WM and cortical MS lesions at 7 T MRI, our approach uses a single MP2RAGE scan and may be of special interest to clinicians and researchers.
Identifiants
pubmed: 30829941
doi: 10.1097/RLI.0000000000000551
pmc: PMC6499666
mid: NIHMS1518257
doi:
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
356-364Subventions
Organisme : Intramural NIH HHS
ID : ZIA NS003119-09
Pays : United States
Références
Neuroimage. 2009 Apr 1;45(2):333-41
pubmed: 19146961
Eur Radiol. 2010 Apr;20(4):915-22
pubmed: 19802613
IEEE Trans Med Imaging. 2016 May;35(5):1229-1239
pubmed: 26886978
J Magn Reson Imaging. 2016 Jun;43(6):1445-54
pubmed: 26606758
J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):60-6
pubmed: 23813636
IEEE Trans Med Imaging. 2015 Jun;34(6):1349-61
pubmed: 25616008
Magn Reson Med. 2010 Jul;64(1):194-202
pubmed: 20572143
Med Image Anal. 2013 Jan;17(1):1-18
pubmed: 23084503
Ann Neurol. 2013 Nov;74(5):669-78
pubmed: 23813441
Neuroimage. 2017 Jul 15;155:159-168
pubmed: 28435096
PLoS One. 2013 Jul 16;8(7):e69294
pubmed: 23874936
Brain. 2015 Apr;138(Pt 4):932-45
pubmed: 25681411
Invest Radiol. 2012 Jun;47(6):346-52
pubmed: 22543966
Invest Radiol. 2017 May;52(5):265-273
pubmed: 27898603
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
IEEE Trans Med Imaging. 1997 Oct;16(5):598-609
pubmed: 9368115
Neuroimage Clin. 2015 May 16;8:367-75
pubmed: 26106562
Neuroimage. 2012 Feb 15;59(4):3774-83
pubmed: 22119648
Eur Radiol. 2013 Feb;23(2):528-40
pubmed: 22898935
IEEE Trans Med Imaging. 1991;10(3):395-407
pubmed: 18222842
Neuroimage. 2010 Jan 15;49(2):1271-81
pubmed: 19819338
Ann Neurol. 2005 Dec;58(6):840-6
pubmed: 16283615
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Neuroimage Clin. 2013 Jan 11;2:184-96
pubmed: 24179773
Neuroimage Clin. 2014 Nov 08;7:7-17
pubmed: 25429357
Brain. 2008 Sep;131(Pt 9):2332-40
pubmed: 18676439
Invest Radiol. 2009 Sep;44(9):491-4
pubmed: 19652606
Neurology. 2009 Sep 22;73(12):941-8
pubmed: 19641168
Ann Neurol. 2016 Nov;80(5):776-790
pubmed: 27686563
Neuroimage. 2010 Jan 15;49(2):1524-35
pubmed: 19766196
Brain. 2016 May;139(Pt 5):1472-81
pubmed: 26956422
AJNR Am J Neuroradiol. 2018 Mar;39(3):459-466
pubmed: 29439120
AJNR Am J Neuroradiol. 2015 Jul;36(7):1204-15
pubmed: 25523591
Med Image Comput Comput Assist Interv. 2014;17(Pt 1):771-8
pubmed: 25333189
Invest Radiol. 2016 Aug;51(8):469-82
pubmed: 26863580
Invest Radiol. 2014 May;49(5):290-8
pubmed: 24566291
AJNR Am J Neuroradiol. 2005 Mar;26(3):572-7
pubmed: 15760868
Neuroimage. 2017 Mar 1;148:77-102
pubmed: 28087490